222 related articles for article (PubMed ID: 22115963)
1. Early ROS-mediated DNA damage and oxidative stress biomarkers in Monoclonal B Lymphocytosis.
Collado R; Oliver I; Tormos C; Egea M; Miguel A; Cerdá C; Ivars D; Borrego S; Carbonell F; Sáez GT
Cancer Lett; 2012 Apr; 317(2):144-9. PubMed ID: 22115963
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia.
Oltra AM; Carbonell F; Tormos C; Iradi A; Sáez GT
Free Radic Biol Med; 2001 Jun; 30(11):1286-92. PubMed ID: 11368926
[TBL] [Abstract][Full Text] [Related]
5. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
Rawstron AC; Bennett F; Hillmen P
Br J Haematol; 2007 Dec; 139(5):724-9. PubMed ID: 18021087
[TBL] [Abstract][Full Text] [Related]
6. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Popp HD; Flach J; Brendel S; Ruppenthal S; Kleiner H; Seifarth W; Schneider S; Schulze TJ; Weiss C; Wenz F; Hofmann WK; Fabarius A
Leuk Lymphoma; 2019 Mar; 60(3):795-804. PubMed ID: 30376743
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of oxidative stress and DNA damage in agricultural workers: a pilot study.
Muniz JF; McCauley L; Scherer J; Lasarev M; Koshy M; Kow YW; Nazar-Stewart V; Kisby GE
Toxicol Appl Pharmacol; 2008 Feb; 227(1):97-107. PubMed ID: 18086483
[TBL] [Abstract][Full Text] [Related]
10. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension.
Espinosa O; Jiménez-Almazán J; Chaves FJ; Tormos MC; Clapes S; Iradi A; Salvador A; Fandos M; Redón J; Sáez GT
Free Radic Res; 2007 May; 41(5):546-54. PubMed ID: 17454137
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia.
Matos DM; Ismael SJ; Scrideli CA; de Oliveira FM; Rego EM; Falcão RP
Br J Haematol; 2009 Nov; 147(3):339-46. PubMed ID: 19709083
[TBL] [Abstract][Full Text] [Related]
12. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics.
Nieto WG; Teodosio C; López A; Rodríguez-Caballero A; Romero A; Bárcena P; Gutierrez ML; Langerak AW; Fernandez-Navarro P; Orfao A; Almeida J;
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S24-34. PubMed ID: 20839335
[TBL] [Abstract][Full Text] [Related]
13. CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?
Scarfò L; Dagklis A; Scielzo C; Fazi C; Ghia P
Semin Cancer Biol; 2010 Dec; 20(6):384-90. PubMed ID: 20816789
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients.
Zelen I; Djurdjevic P; Popovic S; Stojanovic M; Jakovljevic V; Radivojevic S; Baskic D; Arsenijevic N
J BUON; 2010; 15(2):330-6. PubMed ID: 20658731
[TBL] [Abstract][Full Text] [Related]
15. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
Scarfò L; Ghia P
Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
[TBL] [Abstract][Full Text] [Related]
16. High DNA oxidative damage in systemic sclerosis.
Avouac J; Borderie D; Ekindjian OG; Kahan A; Allanore Y
J Rheumatol; 2010 Dec; 37(12):2540-7. PubMed ID: 20843906
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal B-cell lymphocytosis: recommendations from the Dutch Working Group on CLL for daily practice.
te Raa GD; van Oers MH; Kater AP;
Neth J Med; 2012 Jun; 70(5):236-41. PubMed ID: 22744928
[TBL] [Abstract][Full Text] [Related]
18. [Study of oxidative stress in advanced kidney disease].
Puchades Montesa MJ; González Rico MA; Solís Salguero MA; Torregrosa Maicas I; Tormos Muñoz MC; Saez Tormo G; Juan Garcia I; Miguel Carrasco A
Nefrologia; 2009; 29(5):464-73. PubMed ID: 19820759
[TBL] [Abstract][Full Text] [Related]
19. Urinary biomarkers of oxidative/nitrosative stress in healthy smokers.
Campos C; Guzmán R; López-Fernández E; Casado Á
Inhal Toxicol; 2011 Feb; 23(3):148-56. PubMed ID: 21391783
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress accelerates spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes.
Djurdjevic P; Zelen I; Ristic P; Jovanovic I; Jakovljevic V; Baskic D; Popovic S; Arsenijevic N
J BUON; 2009; 14(2):281-7. PubMed ID: 19650179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
